Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

A new method for treating male pattern baldness in men with a low chance of improvement was discussed.

Fluoric Acid helps regrow hair and reduces relapse in Alopecia Areata.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

ALDOA levels drop in hair cells during hair loss.

The guideline provides recommendations for managing alopecia areata effectively.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

People with autism are more likely to develop alopecia areata than those without autism.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

SVF and PRP improve hair loss, but SVF causes more side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Flavin prevents cataracts in young rats.

Created microspheres show potential for safe and effective use in prostate artery embolization.

HASHA is a safe and effective option for chin augmentation.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

A 4-year-old had a rare type of hair loss that may have a good outcome.

Certain genetic variations in the A2M gene are linked to better milk quality in Murrah buffaloes.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.